Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol versus cinacalcet for secondary hyperparathyroidism in hemodialysis patients
ChiCTR2000031420Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Mar 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in secondary hyperparathyroidism (SHPT) comparing Paricalcitol Group with Cinacalcet Group (2 arms). Primary endpoint: intact parathyroid hormone. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
paricalcitolcinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on ChiCTR2000031420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031420.